TY - JOUR T1 - Cost Effectiveness of Outpatient Asthma Clinics JO - Archivos de Bronconeumología T2 - AU - Pérez de Llano,Luis A. AU - Villoro,Renata AU - Merino,María AU - Neira,Maria del Carmen Gómez AU - Muñiz,Camino AU - Hidalgo,Álvaro SN - 15792129 M3 - 10.1016/j.arbr.2016.02.009 DO - 10.1016/j.arbr.2016.02.009 UR - https://archbronconeumol.org/en-cost-effectiveness-outpatient-asthma-clinics-articulo-S1579212916000343 AB - IntroductionAsthma clinics (AC) are hospital outpatient services specializing in the management of asthma. In this study, we analyzed the impact of these clinics on asthma management and their cost effectiveness in comparison with standard outpatient services. MethodsA case–crossover study in which all new patients seen in the AC of Lugo in 2012 were included. The case period was defined as one year following the first visit to the AC; the control period was defined as the preceding year. We calculated changes in clinical quality indicators for asthma management, and estimated the incremental cost-effectiveness ratio (ICER) for each additional patient treated and for each quality-adjusted life year (QALY). ResultsThe number of patients (n=83, mean age 49±15.2years; 60.2% women) managed in the AC increased from 41% to 86%. The asthma control test score increased from 18.7±4.6 to 22.6±2.3 (P<.05) and FEV1 increased from 81.4±17.5% to 84.4±16.6% (P<.05). The number of exacerbations, hospitalizations and visits for accident and emergency fell by 75%. The number of patients given combination LABA+ICS therapy fell from 79.5% to 41%. The use of other drug therapies increased as the following: anticholinergics, from 3.6% to 16.9%; ICS in monotherapy, from 3.6% to 45.8%; and omalizumab, from 0% to 6%. ICERs per patient managed and per QALY gained were €1399 and €6876, respectively (social perspective). ConclusionsTreatment in ACs is cost effective and beneficial in asthma management. ER -